CXCR4 and breast carcinoma: Reduced expression of CXCR4 in metastatic lesions as compared to corresponding primary tumors has been reported in breast carcinoma, and hypothesized to be due to CXCL12-induced internalization and degradation and/or lower microenvironmental HIF-1α levels[28].